Gastric Cancer With Peritoneal Dissemination
1 clinical trials · Condition
◉ Watch Gastric Cancer With Peritoneal Dissemination
| Record | Firm | Date |
|---|---|---|
| An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II (NCT06232434) | Research Institute for Physical Chemical Problems of the Belarusian State University | 2025-06-20 |
Track Gastric Cancer With Peritoneal Dissemination automatically
Every clearance here is in the API, with alerts when new ones post.